Pirola A - Search Results

1

Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo.

Massimino L, Palmieri O, Facoetti A, Fuggetta D, Spanò S, Lamparelli LA, D'Alessio S, Cagliani S, Furfaro F, D'Amico F, Zilli A, Fiorino G, Parigi TL, Noviello D, Latiano A, Bossa F, Latiano T, Pirola A, Mologni L, Piazza RG, Abbati D, Perri F, Bonini C, Peyrin-Biroulet L, Malesci A, Jairath V, Danese S, Ungaro F. Massimino L, et al. Among authors: pirola a. Gut. 2023 Oct;72(10):1838-1847. doi: 10.1136/gutjnl-2022-328375. Epub 2023 Feb 14. Gut. 2023. PMID: 36788014 Free PMC article.

2

Synergistic activity of the Src/Abl inhibitor bosutinib in combination with imatinib.

Redaelli S, Boschelli F, Perini P, Pirola A, Viltadi M, Gambacorti-Passerini C. Redaelli S, et al. Among authors: pirola a. Leukemia. 2010 Jun;24(6):1223-7. doi: 10.1038/leu.2010.79. Epub 2010 May 6. Leukemia. 2010. PMID: 20445575 No abstract available.

3

BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients.

Marega M, Piazza RG, Pirola A, Redaelli S, Mogavero A, Iacobucci I, Meneghetti I, Parma M, Pogliani EM, Gambacorti-Passerini C. Marega M, et al. Among authors: pirola a. Leukemia. 2010 Aug;24(8):1445-9. doi: 10.1038/leu.2010.101. Epub 2010 Jun 3. Leukemia. 2010. PMID: 20520635

4

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.

Piazza R, Valletta S, Winkelmann N, Redaelli S, Spinelli R, Pirola A, Antolini L, Mologni L, Donadoni C, Papaemmanuil E, Schnittger S, Kim DW, Boultwood J, Rossi F, Gaipa G, De Martini GP, di Celle PF, Jang HG, Fantin V, Bignell GR, Magistroni V, Haferlach T, Pogliani EM, Campbell PJ, Chase AJ, Tapper WJ, Cross NC, Gambacorti-Passerini C. Piazza R, et al. Among authors: pirola a. Nat Genet. 2013 Jan;45(1):18-24. doi: 10.1038/ng.2495. Epub 2012 Dec 9. Nat Genet. 2013. PMID: 23222956 Free PMC article.

5

Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases.

Spinelli R, Pirola A, Redaelli S, Sharma N, Raman H, Valletta S, Magistroni V, Piazza R, Gambacorti-Passerini C. Spinelli R, et al. Among authors: pirola a. Mol Genet Genomic Med. 2013 Nov;1(4):246-59. doi: 10.1002/mgg3.23. Epub 2013 Jul 7. Mol Genet Genomic Med. 2013. PMID: 24498620 Free PMC article.

6

Treatment Efficacy and Resistance Mechanisms Using the Second-Generation ALK Inhibitor AP26113 in Human NPM-ALK-Positive Anaplastic Large Cell Lymphoma.

Ceccon M, Mologni L, Giudici G, Piazza R, Pirola A, Fontana D, Gambacorti-Passerini C. Ceccon M, et al. Among authors: pirola a. Mol Cancer Res. 2015 Apr;13(4):775-83. doi: 10.1158/1541-7786.MCR-14-0157. Epub 2014 Nov 24. Mol Cancer Res. 2015. PMID: 25421750

7

NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922.

Mologni L, Ceccon M, Pirola A, Chiriano G, Piazza R, Scapozza L, Gambacorti-Passerini C. Mologni L, et al. Among authors: pirola a. Oncotarget. 2015 Mar 20;6(8):5720-34. doi: 10.18632/oncotarget.3122. Oncotarget. 2015. PMID: 25749034 Free PMC article.

8

BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene.

Sharma N, Magistroni V, Piazza R, Citterio S, Mezzatesta C, Khandelwal P, Pirola A, Gambacorti-Passerini C. Sharma N, et al. Among authors: pirola a. Mol Cancer. 2015 Jul 16;14:132. doi: 10.1186/s12943-015-0407-0. Mol Cancer. 2015. PMID: 26179066 Free PMC article.

9

RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients.

Piazza R, Cecchetti C, Pirola A, Donandoni C, Fontana D, Mezzatesta C, Magistroni V, Bianchi B, Borin L, Fumagalli M, Gambacorti-Passerini C. Piazza R, et al. Among authors: pirola a. Am J Hematol. 2015 Dec;90(12):E227-8. doi: 10.1002/ajh.24210. Epub 2015 Nov 17. Am J Hematol. 2015. PMID: 26440066 Free article. No abstract available.

10

Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphoma.

Redaelli S, Ceccon M, Antolini L, Rigolio R, Pirola A, Peronaci M, Gambacorti-Passerini C, Mologni L. Redaelli S, et al. Among authors: pirola a. Oncotarget. 2016 Nov 8;7(45):72886-72897. doi: 10.18632/oncotarget.12128. Oncotarget. 2016. PMID: 27662658 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters